P Wikström

970 total citations
25 papers, 863 citations indexed

About

P Wikström is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, P Wikström has authored 25 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in P Wikström's work include Peptidase Inhibition and Analysis (13 papers), Protease and Inhibitor Mechanisms (9 papers) and Biochemical and Structural Characterization (5 papers). P Wikström is often cited by papers focused on Peptidase Inhibition and Analysis (13 papers), Protease and Inhibitor Mechanisms (9 papers) and Biochemical and Structural Characterization (5 papers). P Wikström collaborates with scholars based in Switzerland, Germany and France. P Wikström's co-authors include E Shaw, Elliott Shaw, Robert W. Mason, Herbert Angliker, Jörg Stürzebecher, Cynthia A. Crawford, Heidrun Kirschke, Dagmar Prasa, Jörg Hauptmann and Stuart R. Stone and has published in prestigious journals such as Analytical Biochemistry, Biochemical Journal and FEBS Letters.

In The Last Decade

P Wikström

25 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Wikström Switzerland 17 445 328 281 153 141 25 863
Chih Min Kam United States 15 589 1.3× 207 0.6× 151 0.5× 77 0.5× 145 1.0× 20 1.1k
Chih-Min Kam United States 21 676 1.5× 361 1.1× 231 0.8× 78 0.5× 127 0.9× 35 1.3k
Didier Belorgey United Kingdom 23 529 1.2× 200 0.6× 458 1.6× 301 2.0× 185 1.3× 34 1.1k
Gary S. Coombs United States 21 839 1.9× 208 0.6× 280 1.0× 102 0.7× 204 1.4× 27 1.3k
Dyfed L. Evans United Kingdom 10 707 1.6× 252 0.8× 478 1.7× 143 0.9× 267 1.9× 10 1.3k
Kylie A. Hotchkiss United States 12 622 1.4× 224 0.7× 169 0.6× 214 1.4× 75 0.5× 13 1.0k
Pierre Beauparlant Canada 16 874 2.0× 329 1.0× 394 1.4× 67 0.4× 96 0.7× 25 1.6k
Karl HOCHSTRASSER Germany 20 764 1.7× 240 0.7× 294 1.0× 195 1.3× 163 1.2× 59 1.3k
Priya Chaturvedi United States 13 1.0k 2.3× 934 2.8× 259 0.9× 242 1.6× 69 0.5× 13 1.8k
Shuraila F. Zerp Netherlands 19 1.0k 2.3× 365 1.1× 135 0.5× 121 0.8× 48 0.3× 28 1.4k

Countries citing papers authored by P Wikström

Since Specialization
Citations

This map shows the geographic impact of P Wikström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Wikström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Wikström more than expected).

Fields of papers citing papers by P Wikström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Wikström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Wikström. The network helps show where P Wikström may publish in the future.

Co-authorship network of co-authors of P Wikström

This figure shows the co-authorship network connecting the top 25 collaborators of P Wikström. A scholar is included among the top collaborators of P Wikström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Wikström. P Wikström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hauptmann, Jörg, et al.. (2002). Influence of Structural Variations in Peptidomimetic 4-Amidinophenylalanine-Derived Thrombin Inhibitors on Plasma Clearance and Biliary Excretion in Rats. Pharmaceutical Research. 19(7). 1027–1033. 10 indexed citations
2.
Stürzebecher, Jörg, Torsten Steinmetzer, Andrea Schweinitz, et al.. (1999). 3-Amidinophenylalanine-based inhibitors of urokinase. Bioorganic & Medicinal Chemistry Letters. 9(21). 3147–3152. 49 indexed citations
3.
Steinmetzer, Torsten, Martin Renatus, A. Eichinger, et al.. (1999). Design and evaluation of novel bivalent thrombin inhibitors based on amidinophenylalanines. European Journal of Biochemistry. 265(2). 598–605. 21 indexed citations
4.
Stürzebecher, Jörg, et al.. (1997). Synthesis and Structure−Activity Relationships of Potent Thrombin Inhibitors:  Piperazides of 3-Amidinophenylalanine. Journal of Medicinal Chemistry. 40(19). 3091–3099. 88 indexed citations
5.
Stürzebecher, Jörg, et al.. (1995). Structure-Actmty Relationships of Inhibitors Derived from 3-Amidinophenylalanine. Journal of enzyme inhibition. 9(1). 87–99. 18 indexed citations
6.
Wikström, P, John Anagli, Herbert Angliker, & Elliott Shaw. (1993). Additional Peptidyl Diazomethyl Ketones, Including Biotinyl Derivatives, Which Affinity-Label Calpain and Related Cysteinyl Proteinases. Journal of enzyme inhibition. 6(4). 259–269. 3 indexed citations
7.
Angliker, Herbert, P Wikström, E Shaw, Charles Brenner, & Robert S. Fuller. (1993). The synthesis of inhibitors for processing proteinases and their action on the Kex2 proteinase of yeast. Biochemical Journal. 293(1). 75–81. 53 indexed citations
8.
Stürzebecher, Jörg, et al.. (1992). Interactions of Thrombin with Benzamidine-based Inhibitors. Biological Chemistry Hoppe-Seyler. 373(2). 491–496. 16 indexed citations
9.
Stone, Stuart R., et al.. (1992). Peptidyldiazomethanes. A novel mechanism of interaction with prolyl endopeptidase. Biochemical Journal. 283(3). 871–876. 12 indexed citations
10.
Angliker, Herbert, P Wikström, & E Shaw. (1990). Pseudoarginine: synthesis and properties of derivatives of delta-(1-imidazolyl)norvaline.. PubMed. 266(3). 829–34. 6 indexed citations
11.
Buttle, David J., Anka Ritonja, Pamela M. Dando, et al.. (1990). Interactions of papaya proteinase IV with inhibitors. FEBS Letters. 262(1). 58–60. 34 indexed citations
12.
Garten, Wolfgang, et al.. (1989). Inhibition of proteolytic activation of influenza virus hemagglutinin by specific peptidyl chloroalkyl ketones. Virology. 172(1). 25–31. 54 indexed citations
13.
Wikström, P, Heidrun Kirschke, Stuart R. Stone, & Elliott Shaw. (1989). The properties of peptidyl diazoethanes and chloroethanes as protease inactivators. Archives of Biochemistry and Biophysics. 270(1). 286–293. 13 indexed citations
14.
Angliker, Herbert, P Wikström, Heidrun Kirschke, & E Shaw. (1989). The inactivation of the cysteinyl exopeptidases cathepsin H and C by affinity-labelling reagents. Biochemical Journal. 262(1). 63–68. 28 indexed citations
15.
Wikström, P, et al.. (1988). Iodination of peptidyl chloromethyl ketones for protease affinity labels. Analytical Biochemistry. 168(2). 259–264. 16 indexed citations
16.
Kirschke, Heidrun, P Wikström, & Elliott Shaw. (1988). Active center differences between cathepsins L and B: The S1 binding region. FEBS Letters. 228(1). 128–130. 55 indexed citations
17.
Angliker, Herbert, et al.. (1988). Synthesis and properties of peptidyl derivatives of arginylfluoromethanes. Biochemical Journal. 256(2). 481–486. 29 indexed citations
18.
Angliker, Herbert, et al.. (1987). The synthesis of lysylfluoromethanes and their properties as inhibitors of trypsin, plasmin and cathepsin B. Biochemical Journal. 241(3). 871–875. 43 indexed citations
19.
Angliker, Herbert, et al.. (1986). Peptidyl fluoromethyl ketones as thiol protease inhibitors.. PubMed. 45(11-12). 1397–403. 13 indexed citations
20.
Walker, Brian, P Wikström, & E Shaw. (1985). Evaluation of inhibitor constants and alkylation rates for a series of thrombin affinity labels. Biochemical Journal. 230(3). 645–650. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chih Min Kam Breakdown of academic impact, for papers by Chih-Min Kam Breakdown of academic impact, for papers by Didier Belorgey Breakdown of academic impact, for papers by Gary S. Coombs Breakdown of academic impact, for papers by Dyfed L. Evans Breakdown of academic impact, for papers by Kylie A. Hotchkiss Breakdown of academic impact, for papers by Pierre Beauparlant Breakdown of academic impact, for papers by Karl HOCHSTRASSER Breakdown of academic impact, for papers by Priya Chaturvedi Breakdown of academic impact, for papers by Shuraila F. Zerp
Rankless by CCL
2026